
Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.
(Reporting by Pedro Fonseca)

Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.
(Reporting by Pedro Fonseca)